High-grade glioma patients at UVA now have the opportunity to participate in Toca 5, an international clinical trial of a new, virus-based procedure that activates therapeutics selectively within the brain tumor, leading to fewer side effects.
High-grade glioma patients at UVA now have the opportunity to participate in Toca 5, an international clinical trial of a new, virus-based procedure that activates therapeutics selectively within the brain tumor, leading to fewer side effects.